{"id":"https://openalex.org/W2886984151","doi":"https://doi.org/10.1158/1538-7445.am2018-3945","title":"Abstract 3945: CBT-102, an oral multi-kinase small molecule, demonstrates favorable activity in human hepatocellular carcinoma animal models and cardiac safety in rabbit Purkinje and beagle dogs compared to sorafenib","display_name":"Abstract 3945: CBT-102, an oral multi-kinase small molecule, demonstrates favorable activity in human hepatocellular carcinoma animal models and cardiac safety in rabbit Purkinje and beagle dogs compared to sorafenib","alternate_titles":[],"publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2886984151","doi":"https://doi.org/10.1158/1538-7445.am2018-3945","mag":"2886984151"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-3945","doi":"https://doi.org/10.1158/1538-7445.am2018-3945","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-3945","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2886984151"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091035596","display_name":"Sarath Kanekal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarath Kanekal","raw_affiliation_strings":["1CBT Pharmaceuticals, Inc., Pleasanton, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CBT Pharmaceuticals, Inc., Pleasanton, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033736862","display_name":"Xiquan Zhang","orcid":"https://orcid.org/0000-0002-7940-1303","observed_orcids":["https://orcid.org/0000-0002-7940-1303"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiquan Zhang","raw_affiliation_strings":["2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023714188","display_name":"Yanrui Song","orcid":"https://orcid.org/0000-0001-6717-7247","observed_orcids":["https://orcid.org/0000-0001-6717-7247"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yanrui Song","raw_affiliation_strings":["2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036010791","display_name":"Tan Wenmiao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tan Wenmiao","raw_affiliation_strings":["2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100390024","display_name":"Juan Zhang","orcid":"https://orcid.org/0000-0002-2572-1379","observed_orcids":["https://orcid.org/0000-0002-2572-1379"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Juan Zhang","raw_affiliation_strings":["2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Deyi Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Deyi Zhang","raw_affiliation_strings":["2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101797368","display_name":"Henry Li","orcid":"https://orcid.org/0000-0002-4673-1234","observed_orcids":["https://orcid.org/0000-0002-4673-1234"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henry Li","raw_affiliation_strings":["2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Crown Biosciences, Inc., Taicang City, Jiangsu Province, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112251494","display_name":"Mamatha Reddy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mamatha Reddy","raw_affiliation_strings":["1CBT Pharmaceuticals, Inc., Pleasanton, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CBT Pharmaceuticals, Inc., Pleasanton, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039840799","display_name":"Gavin S. Choy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gavin Choy","raw_affiliation_strings":["1CBT Pharmaceuticals, Inc., Pleasanton, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CBT Pharmaceuticals, Inc., Pleasanton, CA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020548821","display_name":"Sanjeev Redkar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sanjeev Redkar","raw_affiliation_strings":["1CBT Pharmaceuticals, Inc., Pleasanton, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CBT Pharmaceuticals, Inc., Pleasanton, CA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"3945","last_page":"3945"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.8230000138282776},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9190000295639038},{"id":"https://openalex.org/keywords/cardiac-safety","display_name":"cardiac safety","score":0.7580000162124634},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7310000061988831},{"id":"https://openalex.org/keywords/vegfr","display_name":"VEGFR","score":0.5879999995231628},{"id":"https://openalex.org/keywords/pdgfr","display_name":"PDGFR","score":0.968999981880188},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8009999990463257},{"id":"https://openalex.org/keywords/braf","display_name":"BRAF","score":0.8360000252723694},{"id":"https://openalex.org/keywords/raf-1","display_name":"Raf-1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/ret","display_name":"RET","score":0.8040000200271606},{"id":"https://openalex.org/keywords/csf1r","display_name":"CSF1R","score":0.9769999980926514},{"id":"https://openalex.org/keywords/c-kit","display_name":"CD117","score":0.9779999852180481},{"id":"https://openalex.org/keywords/flt3","display_name":"FLT3","score":0.9929999709129333},{"id":"https://openalex.org/keywords/purkinje-fibers","display_name":"Purkinje fibers","score":0.8389999866485596},{"id":"https://openalex.org/keywords/action-potential","display_name":"action potential","score":0.7139999866485596},{"id":"https://openalex.org/keywords/ecg-telemetry","display_name":"ECG telemetry","score":0.7409999966621399},{"id":"https://openalex.org/keywords/beagle","display_name":"beagle dogs","score":0.8619999885559082},{"id":"https://openalex.org/keywords/rabbits","display_name":"rabbits","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.8428088426589966},{"id":"https://openalex.org/C2776820430","wikidata":"https://www.wikidata.org/wiki/Q21102","display_name":"Beagle","level":2,"score":0.8241875171661377},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6543112397193909},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6228511929512024},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.5370956659317017},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4789857864379883},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.47153526544570923},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.44083455204963684},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41503775119781494},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33088427782058716},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.17788031697273254},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-3945","doi":"https://doi.org/10.1158/1538-7445.am2018-3945","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-3945","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1997533142","https://openalex.org/W2047964609","https://openalex.org/W2167161551","https://openalex.org/W4225854270","https://openalex.org/W2158933105","https://openalex.org/W4244298582","https://openalex.org/W2002784910","https://openalex.org/W2792490820","https://openalex.org/W2347673490","https://openalex.org/W2091957929"],"abstract_inverted_index":{"Background:":[0],"Cancer":[1,445,458],"is":[2,34],"a":[3,285,317,381],"complex":[4],"disease":[5],"involving":[6],"disruption":[7],"of":[8,66,232,267,278,302,308,440],"more":[9],"than":[10,289],"one":[11],"receptor":[12],"or":[13,211,273],"signaling":[14],"pathway.":[15],"Inhibiting":[16],"multiple":[17],"oncogenic":[18,41],"targets":[19],"have":[20,366],"been":[21],"shown":[22],"to":[23,57,70,113,173,240,270,284,359,365,435],"be":[24],"an":[25,35,300,411],"important":[26],"strategy":[27],"in":[28,55,72,79,90,96,171,215,281,324,328,335,346,354,385,419,428],"managing":[29],"relapse":[30],"and":[31,47,53,62,83,85,95,110,133,136,157,162,178,208,213,237,254,258,343,361,425,431],"resistance.":[32],"CBT-102":[33,67,122,146,204,233,257,275,298,313,350,373],"oral":[36,230,412],"mTKI":[37],"inhibiting":[38,58],"several":[39],"key":[40],"drivers":[42],"including":[43],"angiogenesis":[44],"via":[45,51,244],"VEGFR":[46],"PDGFR,":[48],"MAPK":[49],"pathway":[50],"B-RAF":[52],"C-RAF,":[54],"addition":[56,172],"RET,":[59],"CSF1R,":[60],"c-KIT,":[61],"FLT3.":[63],"Antitumor":[64],"activity":[65,418],"was":[68,88,123,147],"compared":[69,358,434],"sorafenib":[71,137,165,212,259,290,360,436],"two":[73],"human":[74,420],"primary":[75],"HCC":[76,355],"carcinoma":[77,422],"xenografts":[78,356],"nude":[80,104],"mice":[81,105],"(LIMsh050":[82],"PLCPRF5)":[84],"cardiac":[86,184,318,336,368,426],"safety":[87,185,427],"evaluated":[89],"rabbit":[91,187,194,329,429],"heart":[92,196],"Purkinje":[93,188,330,430],"fibers":[94,189,331],"conscious":[97],"telemeterized":[98],"beagle":[99,241,347,432],"dogs.":[100,348],"Methods:":[101],"Female":[102],"BALB/c":[103],"were":[106,180,190,218,226,261,321],"inoculated":[107],"with":[108,201,264,371,380],"LIMsh050":[109,120,253],"PLCPRF5":[111,144,255,296],"tumors":[112],"establish":[114],"the":[115,119,143,183,221,252,295,367,441],"tumor":[116,174,279],"models.":[117],"In":[118,142,168,220,250,294],"model,":[121,145,297],"administered":[124,148],"orally":[125,149],"QD":[126,150],"x":[127,151],"21":[128],"days":[129,153],"at":[130,138,154,234,291],"4,":[131],"10,":[132],"25":[134],"mg/kg":[135,140,159,164,239,304,307],"10":[139,199,209],"(n=8/group).":[141],"14":[152],"3,":[155,207],"8,":[156],"20":[158,163],"vs.":[160,305],"8":[161],"group":[166],"(n=7/group).":[167],"both":[169,251,282],"experiments,":[170],"volume,":[175],"body":[176],"weight":[177,271],"mortality":[179],"monitored.":[181],"For":[182],"studies,":[186],"isolated":[191],"from":[192],"adult":[193],"right":[195],"perfused":[197],"for":[198,246,444],"minutes":[200],"vehicle":[202],"control,":[203],"groups":[205],"(1,":[206],"\u00b5M)":[210],"changes":[214,323,334],"action":[216,325],"potentials":[217],"measured.":[219],"second":[222],"study,":[223],"ECG":[224],"parameters":[225,338],"measured":[227],"after":[228],"single":[229],"administration":[231],"15,":[235],"45,":[236],"67.5":[238],"dogs":[242,433],"(n=6/group)":[243],"telemetry":[245],"24":[247],"h.":[248],"Results:":[249],"models,":[256,283],"doses":[260],"well":[262],"tolerated":[263],"no":[265,322],"suspension":[266],"dosing":[268],"due":[269],"loss":[272],"deaths.":[274],"demonstrated":[276,299,351],"inhibition":[277],"growth":[280],"significantly":[286],"greater":[287],"extent":[288],"comparable":[292],"doses.":[293],"ED50":[301],"2.5":[303],"16.8":[306],"sorafenib.":[309,372],"Importantly,":[310],"unlike":[311],"sorafenib,":[312],"did":[314],"not":[315,363],"show":[316],"liability:":[319],"there":[320],"potential":[326,382],"duration":[327],"nor":[332],"any":[333],"conduction":[337],"(HR,":[339],"QTc,":[340],"RR,":[341],"PR,":[342],"QRS":[344],"intervals)":[345],"Conclusions:":[349],"improved":[352],"efficacy":[353],"models":[357,424],"does":[362],"appear":[364],"liability":[369],"observed":[370],"will":[374],"advance":[375],"into":[376],"GLP":[377],"toxicology":[378],"studies":[379],"IND":[383],"filing":[384],"2H":[386],"2018.":[387],"Citation":[388],"Format:":[389],"Sarath":[390],"Kanekal,":[391],"Xiquan":[392],"Zhang,":[393,399,401],"Yanrui":[394],"Song,":[395],"Tan":[396],"Wenmiao,":[397],"Juan":[398],"Deyi":[400],"Henry":[402],"Li,":[403],"Mamatha":[404],"Reddy,":[405],"Gavin":[406],"Choy,":[407],"Sanjeev":[408],"Redkar.":[409],"CBT-102,":[410],"multi-kinase":[413],"small":[414],"molecule,":[415],"demonstrates":[416],"favorable":[417],"hepatocellular":[421],"animal":[423],"[abstract].":[437],"In:":[438],"Proceedings":[439],"American":[442],"Association":[443],"Research":[446],"Annual":[447],"Meeting":[448],"2018;":[449],"2018":[450],"Apr":[451],"14-18;":[452],"Chicago,":[453],"IL.":[454],"Philadelphia":[455],"(PA):":[456],"AACR;":[457],"Res":[459],"2018;78(13":[460],"Suppl):Abstract":[461],"nr":[462],"3945.":[463]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2886984151","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-08-22T00:00:00"}
